Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Obesity × Tirzepatide × Clear all

Phase

Phase EARLY_PHASE1 2 Phase 2 2 Phase 4 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Obesity 1 Breast Neoplasms 1

Interventions

Metformin 6 Exercise 3 Liraglutide 2 Docosahexaenoic Acids 2 Diet 2 sibutramine 1 semaglutide 1 Ursodeoxycholic Acid 1 Topiramate 1 Tirzepatide 1 Propofol 1 Nutrition Therapy 1 Nutrition Assessment 1 Exenatide 1 Doxorubicin 1 Cyclophosphamide 1 Caloric Restriction 1 (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Weill Medical College of Cornell University

Phase 4 Not yet recruiting

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡